Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2007

View Archived Issues

Novel animation depicting GLP-1 and DPP IV as therapeutic targets for diabetes and obesity

STRIDE preliminary results reveal safety and activity of I-vation Triamcinolone Intravitreal Implant

Common pathogenic mechanisms in AD and ocular degenerative diseases

Recent patents disclose new anxiolytic and antipsychotic agents

Therapeutic agents for allergic and respiratory disorders described in recent patents

Promising neuroprotective and antioxidant effects of AEOL-11207 in an MPTP model of Parkinsonism

Recent patents impart novel treatment options for autoimmune and inflammatory disorders

Accentia reaches milestone in SinuNase development; CRSFungal Profile commercialized

Commercialization agreement signed for NeuroBloc

ODAC to review satraplatin in July

Paramount BioSciences obtains license to SonoLight technology for dermatology indications

Boehringer Ingelheim announces measure to expand reach of HIV therapy

Patient enrollment begins in Aridol trial for COPD

Interim analysis of talabostat phase III NSCLC clinical trial to be conducted

SIGA's Lassa fever drug candidate shows promise in animal models

Indaflex shows potential in phase II for osteoarthritis

Testosterone improves cognitive performance in multiple sclerosis

Promising phase IIa study results reported for house dust mite allergy product candidate

Oxycyte reaches primary endpoint in TBI phase IIa trial

Luitpold seeks FDA approval for iron replacement therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...